253 related articles for article (PubMed ID: 28619018)
21. Functional antibody single-chain fragments from the cytoplasm of Escherichia coli: influence of thioredoxin reductase (TrxB).
Proba K; Ge L; Plückthun A
Gene; 1995 Jul; 159(2):203-7. PubMed ID: 7622050
[TBL] [Abstract][Full Text] [Related]
22. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.
Nativel B; Figuester A; Andries J; Planesse C; Couprie J; Gasque P; Viranaicken W; Iwema T
J Immunol Methods; 2016 Dec; 439():67-73. PubMed ID: 27742562
[TBL] [Abstract][Full Text] [Related]
23. Heterologous production of active ribonuclease inhibitor in Escherichia coli by redox state control and chaperonin coexpression.
Šiurkus J; Neubauer P
Microb Cell Fact; 2011 Aug; 10():65. PubMed ID: 21824411
[TBL] [Abstract][Full Text] [Related]
24. Media optimization for SHuffle T7 Escherichia coli expressing SUMO-Lispro proinsulin by response surface methodology.
Khalilvand AB; Aminzadeh S; Sanati MH; Mahboudi F
BMC Biotechnol; 2022 Jan; 22(1):1. PubMed ID: 34980082
[TBL] [Abstract][Full Text] [Related]
25. Effective production of single-chain variable fragment (scFv) antibody using recombinant Escherichia coli by DO-stat fed-batch culture.
Nghia NH; Kumada Y; Kishimoto M; Horiuchi JI
J Biosci Bioeng; 2021 Jul; 132(1):56-63. PubMed ID: 33896701
[TBL] [Abstract][Full Text] [Related]
26. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
[TBL] [Abstract][Full Text] [Related]
27. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
Panda AK
Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
[TBL] [Abstract][Full Text] [Related]
28. Efficient Production of Fc Fusion Proteins in the Cytoplasm of
Tungekar AA; Ruddock LW
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499069
[TBL] [Abstract][Full Text] [Related]
29. Chemical treatment of Escherichia coli: 3. Selective extraction of a recombinant protein from cytoplasmic inclusion bodies in intact cells.
Falconer RJ; O'Neill BK; Middelberg AP
Biotechnol Bioeng; 1999 Feb; 62(4):455-60. PubMed ID: 9921154
[TBL] [Abstract][Full Text] [Related]
30. Optimized Production of Disulfide-Bonded Fungal Effectors in
Yu DS; Outram MA; Crean E; Smith A; Sung YC; Darma R; Sun X; Ma L; Jones DA; Solomon PS; Williams SJ
Mol Plant Microbe Interact; 2022 Feb; 35(2):109-118. PubMed ID: 34672679
[TBL] [Abstract][Full Text] [Related]
31. Development of scale-down techniques for investigation of recombinant Escherichia coli fermentations: acid metabolites in shake flasks and stirred bioreactors.
Dahlgren ME; Powell AL; Greasham RL; George HA
Biotechnol Prog; 1993; 9(6):580-6. PubMed ID: 7764346
[TBL] [Abstract][Full Text] [Related]
32. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
Venturi M; Seifert C; Hunte C
J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
[TBL] [Abstract][Full Text] [Related]
33. Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin.
Jurado P; de Lorenzo V; Fernández LA
J Mol Biol; 2006 Mar; 357(1):49-61. PubMed ID: 16427080
[TBL] [Abstract][Full Text] [Related]
34. Soluble expression of disulfide bond containing proteins FGF15 and FGF19 in the cytoplasm of Escherichia coli.
Kong B; Guo GL
PLoS One; 2014; 9(1):e85890. PubMed ID: 24465767
[TBL] [Abstract][Full Text] [Related]
35. Use of a stress-minimisation paradigm in high cell density fed-batch Escherichia coli fermentations to optimise recombinant protein production.
Wyre C; Overton TW
J Ind Microbiol Biotechnol; 2014 Sep; 41(9):1391-404. PubMed ID: 25056840
[TBL] [Abstract][Full Text] [Related]
36. High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli.
Nozach H; Fruchart-Gaillard C; Fenaille F; Beau F; Ramos OH; Douzi B; Saez NJ; Moutiez M; Servent D; Gondry M; Thaï R; Cuniasse P; Vincentelli R; Dive V
Microb Cell Fact; 2013 Apr; 12():37. PubMed ID: 23607455
[TBL] [Abstract][Full Text] [Related]
37. Comparative proteome analysis in an Escherichia coli CyDisCo strain identifies stress responses related to protein production, oxidative stress and accumulation of misfolded protein.
Guerrero Montero I; Dolata KM; Schlüter R; Malherbe G; Sievers S; Zühlke D; Sura T; Dave E; Riedel K; Robinson C
Microb Cell Fact; 2019 Jan; 18(1):19. PubMed ID: 30696436
[TBL] [Abstract][Full Text] [Related]
38. Analysis of single-chain antibody production in Pichia pastoris using on-line methanol control in fed-batch and mixed-feed fermentations.
Hellwig S; Emde F; Raven NP; Henke M; van Der Logt P; Fischer R
Biotechnol Bioeng; 2001 Aug; 74(4):344-52. PubMed ID: 11410859
[TBL] [Abstract][Full Text] [Related]
39. Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli.
Tabandeh F; Shojaosadati SA; Zomorodipour A; Khodabandeh M; Sanati MH; Yakhchali B
Biotechnol Lett; 2004 Feb; 26(3):245-50. PubMed ID: 15049371
[TBL] [Abstract][Full Text] [Related]
40. Purification of secreted recombinant proteins from Escherichia coli.
Le HV; Trotta PP
Bioprocess Technol; 1991; 12():163-81. PubMed ID: 1367083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
